Oral diamorphine: lack of effect on dyspnoea and exercise tolerance in the "pink puffer" syndrome
- PMID: 1783082
Oral diamorphine: lack of effect on dyspnoea and exercise tolerance in the "pink puffer" syndrome
Abstract
The aim of this study was to assess the effects of diamorphine on breathlessness and exercise tolerance in patients with severe chronic airflow obstruction and normal arterial carbon dioxide tension (PCO2) levels ("pink puffer" syndrome). In this double-blind, cross-over, randomized study we examined both acute and chronic effects of single and multiple doses of oral diamorphine in 14 "pink puffer" patients. Their mean resting forced expiratory volume in one second (FEV1) was 36% predicted normal, mean arterial oxygen tension (PaO2) was 9.2 kPa and mean PaCO2 was 5.2 kPa. Ten patients took either diamorphine 2.5 or 5 mg or placebo elixir 6 hourly for 2 weeks, recording on a diary card dyspnoea, sleepiness and well-being on a visual analogue scale (VAS). The final treatment was given 30 min before measuring spirometry, arterial blood gases, plasma morphine levels, 6 min walking distances, time walked on treadmill and self-assessment of dyspnoea on a VAS scale after exercise. On two further days, eight patients took two doses, 4 h apart, of either diamorphine 7.5 mg or placebo elixir. Spirometry, 6 min walking distance with a VAS score for dyspnoea were measured before and at 1 h after each dose. Morphine levels and blood gases were also measured. Whether given in single or repeated doses, oral diamorphine had no significant effect on exercise tolerance and breathlessness when compared with placebo. Diamorphine 2.5-7.5 mg produced neither sleepiness nor a deterioration in blood gases. However, plasma levels associated with analgesic efficacy were not achieved with these doses. Thus, as given in this study, oral diamorphine is unlikely to have therapeutic potential in the treatment of dyspnoea in the "pink puffer" syndrome.
Similar articles
-
[Value of orally administered retard morphine for therapy of severe pulmonary emphysema of the pink-puffer type. A pilot study].Dtsch Med Wochenschr. 1998 Nov 27;123(48):1433-8. doi: 10.1055/s-2007-1024198. Dtsch Med Wochenschr. 1998. PMID: 9858950 Clinical Trial. German.
-
Lack of effect of dextromethorphan on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease (COPD).Eur Respir J. 1991 May;4(5):532-5. Eur Respir J. 1991. PMID: 1936224
-
Almitrine bismesylate: a long-term placebo-controlled double-blind study in COAD--Vectarion International Multicentre Study Group.Bull Eur Physiopathol Respir. 1987 Aug;23 Suppl 11:169s-182s. Bull Eur Physiopathol Respir. 1987. PMID: 3318971 Clinical Trial.
-
The role of theophylline in the treatment of dyspnea in COPD.Chest. 1987 Jul;92(1 Suppl):2S-6S. doi: 10.1378/chest.92.1_supplement.2s. Chest. 1987. PMID: 3297522 Review.
-
Pharmacokinetic modeling and simulation to understand diamorphine dose-response in neonates, children, and adolescents.Paediatr Anaesth. 2022 Jun;32(6):716-726. doi: 10.1111/pan.14425. Epub 2022 Mar 1. Paediatr Anaesth. 2022. PMID: 35212432 Review.
Cited by
-
Use of short-acting opioids in the management of breathlessness: an evidence-based review.Curr Opin Support Palliat Care. 2020 Sep;14(3):167-176. doi: 10.1097/SPC.0000000000000509. Curr Opin Support Palliat Care. 2020. PMID: 32701856 Free PMC article. Review.
-
A survey of the views of palliative care healthcare professionals towards referring cancer patients to participate in randomized controlled trials in palliative care.Support Care Cancer. 2008 Dec;16(12):1397-405. doi: 10.1007/s00520-008-0441-1. Epub 2008 May 1. Support Care Cancer. 2008. PMID: 18449574
-
Opioid Prescription Method for Breathlessness Due to Non-Cancer Chronic Respiratory Diseases: A Systematic Review.Int J Environ Res Public Health. 2022 Apr 18;19(8):4907. doi: 10.3390/ijerph19084907. Int J Environ Res Public Health. 2022. PMID: 35457773 Free PMC article.
-
Opioids: an unexplored option for treatment of dyspnea in IPF.Eur Clin Respir J. 2016 Mar 10;3:30629. doi: 10.3402/ecrj.v3.30629. eCollection 2016. Eur Clin Respir J. 2016. PMID: 26969472 Free PMC article. Review.
-
A systematic review of the use of opioids in the management of dyspnoea.Thorax. 2002 Nov;57(11):939-44. doi: 10.1136/thorax.57.11.939. Thorax. 2002. PMID: 12403875 Free PMC article.